Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
XKEM closed with a bullish hammer over the 200 DMA, right at the top B. Band. Todays low was higher than yesterdays and volume is still strong for the OS size. Accumulation is heavy, it cant remain at these levels for long, has to go up or down soon. The sentiment, momentum and bull market conditions are strong enough to push it higher. It wants to run.
Also, the SAR jumped up today right under the hammer. Tomorrow should be a strong day if it gets the follow through.
Stock Analyzer, XKEM closed with a bullish hammer over the 200 DMA, right at the top B. Band. Todays low was higher than yesterdays and volume is still strong for the OS size. Accumulation is heavy, it cant remain at these levels for long, has to go up or down soon. The sentiment, momentum and bull market conditions are strong enough to push it higher. It wants to run.
Also, the SAR jumped up today right under the hammer. Tomorrow should be a strong day if it gets the follow through.
JKRI long term breakout chart
Completely new company now.
JKRI long term breakout chart
Completely new company now.
XKEM trending up too. Being accumulated
JKRI about to brekaout IMO. HOD test coming.
JKRI major breakout soon. HOD test coming
XKEM Showing serious strength. Its rallying again. 200 DMA is proving strong support.
XKEM Showing serious strength. Its rallying again. 200 DMA is proving strong support.
XKEM chart
Momentum is still strong. If the Sickle Cell drug news hits it should be a multibagger from here.
Golden cross coming
Golden cross coming
XKEM gapping again.
XKEM gappa
XKEM held above the 200DMA today on record volume. Someone was trying to hold its head under water but buys at the close pounded it. Some of the blocks at the low were 2 mil+. This is what started the late day rally.
If this stock gets hit with news it could go ape chit. The interest is strong. More will come with news. Entire OS has turned the past week.
Accumulation/Distribution went to crap today, but the MACD crossed zero, the 200DMA broke and the RSI still has room to run IMO.
Volume is growing steadily every day.
XKEM held above the 200DMA today on record volume. Someone was trying to hold its head under water but buys at the close pounded it. Some of the blocks at the low were 2 mil+. This is what started the late day rally.
If this stock gets hit with news it could go ape chit. The interest is strong. More will come with news. Entire OS has turned the past week.
Accumulation/Distribution went to crap today, but the MACD crossed zero, the 200DMA broke and the RSI still has room to run IMO.
Volume is growing steadily every day.
XKEM held above the 200DMA today on record volume. Someone was trying to hold its head under water but buys at the close pounded it. Some of the blocks at the low were 2 mil+. This is what started the late day rally.
If this stock gets hit with news it could go ape chit. The interest is strong. More will come with news. Entire OS has turned the past week.
Accumulation/Distribution went to crap today, but the MACD crossed zero, the 200DMA broke and the RSI still has room to run IMO.
Volume is growing steadily every day.
XKEM held above the 200DMA today on record volume. Someone was trying to hold its head under water but buys at the close pounded it. Some of the blocks at the low were 2 mil+. This is what started the late day rally.
If this stock gets hit with news it could go ape chit. The interest is strong. More will come with news. Entire OS has turned the past week.
Accumulation/Distribution went to crap today, but the MACD crossed zero, the 200DMA broke and the RSI still has room to run IMO.
Volume is growing steadily every day.
GTEC strong buy
XKEM .014 gonna bust here. Major move coming IMO.
XKEM play of the week IMO. .014 falling fast.
CalbaTech, Through Its Subsidiary, Lifestem, Inc., Enthusiastically Notes the Stem Cell Study Center to Be Established at USC; Lifestem is in the Exact Right Place for Stem Cell Services
IRVINE, Calif., Feb. 27 /PRNewswire-FirstCall/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, said today that it believes that the announcement that the University of Southern California has received $25 million to construct a stem cell research facility at its medical school shows that Southern California will be the national leader for this cutting edge technology.
'We believe that this shows that LifeStem, Inc., our wholly owned subsidiary, which is in charge of our Stem Cell MicroBank(TM) Service for the collection of healthy adult stem cells for storage for potential future therapeutic use, is in the right place at the right time with the right product,' said James DeOlden, CalbaTech CEO.
Previously, a state funding initiative approved by California voters established a state institute for stem cell research. 'I believe that Southern California is going to be the hub for research that could give us answers for the treatment of diabetes, cardiovascular diseases and numerous other diseases,' Mr. DeOlden said.
LifeStem recently announced an agreement with Solana MedSpas to offer its Stem Cell MicroBank(TM) Service to the spa customers and will be working to make the Stem Cell MicroBank(TM) Service the most available and acceptable two tissue adult stem cell banking service in the United States.
About LifeStem
LifeStem, a wholly owned subsidiary of CalbaTech, is positioning itself to become a leading supplier of 'Cellular Logistics.' The Company's focus is to provide services and technologies to facilitate the efficient acquisition and delivery of adult stem cells, development of stem cell delivery devices for clinical applications and clinical applications of specific stem cell based therapies. LifeStem, in addition to being the first company to offer micro collection of stem cells, is also the first company to offer a collection service that collects and stores two different types of stem cells. The Company has filed patent applications for an endoscopic stem cell delivery device and its novel Stem Cell MicroBank(TM) service.
About CalbaTech
CalbaTech, Inc. (OTC Bulletin Board: CLBE) is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions.
Contact:
Paul Knopick E&E Communications
(949) 707-5365
pknopick@eandecommunications.com
Note: Certain statements in this news release may contain 'forward looking' information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, may include forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements. Nothing in this release indicates any relationship whatsoever between CalbaTech, Inc., LifeStem, Inc., and the University of Southern California. Any belief or understanding based upon this release to the contrary is incorrect.
SOURCE CalbaTech, Inc.
Source: PR Newswire (February 27, 2006 - 5:00 AM EST)
News by QuoteMedia
www.quotemedia.com
CalbaTech, Through Its Subsidiary, Lifestem, Inc., Enthusiastically Notes the Stem Cell Study Center to Be Established at USC; Lifestem is in the Exact Right Place for Stem Cell Services
IRVINE, Calif., Feb. 27 /PRNewswire-FirstCall/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, said today that it believes that the announcement that the University of Southern California has received $25 million to construct a stem cell research facility at its medical school shows that Southern California will be the national leader for this cutting edge technology.
'We believe that this shows that LifeStem, Inc., our wholly owned subsidiary, which is in charge of our Stem Cell MicroBank(TM) Service for the collection of healthy adult stem cells for storage for potential future therapeutic use, is in the right place at the right time with the right product,' said James DeOlden, CalbaTech CEO.
Previously, a state funding initiative approved by California voters established a state institute for stem cell research. 'I believe that Southern California is going to be the hub for research that could give us answers for the treatment of diabetes, cardiovascular diseases and numerous other diseases,' Mr. DeOlden said.
LifeStem recently announced an agreement with Solana MedSpas to offer its Stem Cell MicroBank(TM) Service to the spa customers and will be working to make the Stem Cell MicroBank(TM) Service the most available and acceptable two tissue adult stem cell banking service in the United States.
About LifeStem
LifeStem, a wholly owned subsidiary of CalbaTech, is positioning itself to become a leading supplier of 'Cellular Logistics.' The Company's focus is to provide services and technologies to facilitate the efficient acquisition and delivery of adult stem cells, development of stem cell delivery devices for clinical applications and clinical applications of specific stem cell based therapies. LifeStem, in addition to being the first company to offer micro collection of stem cells, is also the first company to offer a collection service that collects and stores two different types of stem cells. The Company has filed patent applications for an endoscopic stem cell delivery device and its novel Stem Cell MicroBank(TM) service.
About CalbaTech
CalbaTech, Inc. (OTC Bulletin Board: CLBE) is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions.
Contact:
Paul Knopick E&E Communications
(949) 707-5365
pknopick@eandecommunications.com
Note: Certain statements in this news release may contain 'forward looking' information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, may include forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements. Nothing in this release indicates any relationship whatsoever between CalbaTech, Inc., LifeStem, Inc., and the University of Southern California. Any belief or understanding based upon this release to the contrary is incorrect.
SOURCE CalbaTech, Inc.
Source: PR Newswire (February 27, 2006 - 5:00 AM EST)
News by QuoteMedia
www.quotemedia.com
CLEB news. Stem cell stocks are heating up.
XKEM gapping through 200 DMA. Kaboom!
200 DMA gap for XKEM. WOOHOO!
XKEM gaping
Shakers, the first run had no news and it has held with very little sell pressure. Someone absorbed a large portion of the float. Now CLBE has based and is ready for the volume/news.
My DD tells me news it due. The companies revenue has been growing steadily each Q and their test deal with Medspas is only for 6 locations. If they land the whole chain the stock will see considerable gains IMO. The Medspa industry is growing like rabbits $#$@
CalbaTech's Subsidiary, LifeStem, Inc., Contracts With Solana MedSpas to Exclusively Offer Its Stem Cell Microbank(TM) to Bank Adult Stem Cells Through Solana MedSpas' National Network
Tuesday December 20, 5:00 am ET
IRVINE, Calif., Dec. 20 /PRNewswire-FirstCall/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE - News), an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, today announced that its wholly owned subsidiary, LifeStem, Inc., has reached an agreement with Solana MedSpas (http://www.solanamedspas.com), the nation's foremost developer and syndicator of medical spas, to exclusively offer LifeStem's Stem Cell MicroBank(TM) Service through Solana MedSpas' national network.
ADVERTISEMENT
In the definitive agreement, LifeStem's Stem Cell MicroBank(TM) will initially be offered in six Solana MedSpas network locations in Southern California. Solana MedSpas expects to have as many as 70 locations open by the end of 2006 and intends to offer the Stem Cell Microbank Service at all locations. "We are extremely pleased that we have formalized an agreement with Solana MedSpas," says LifeStem President Dan Fulkerson, "and are confident that many individuals within the Solana MedSpas client base will take advantage of our Stem Cell MicroBank(TM) Service."
Fulkerson continued, "By beginning with six locations and by adding new locations as Solana MedSpas debuts them, our conservative estimates over the first 12 months of operations project revenues in excess of $3 million, with the potential to exceed $25 million in the next couple of years. We're looking forward to expanding our microbanking model into the growing Solana MedSpas network."
In addition to serving the Solana MedSpas client base, LifeStem is planning an aggressive marketing program of its Stem Cell Microbank(TM) Service, outside of Solana's efforts, which will reach more potential clients.
"We are delighted to finalize our agreement with LifeStem," says John Buckingham, CEO and co-founder of Irvine, Calif.-based Solana MedSpas. "We are now ready to move to the beta test phase at selected medspa locations," Buckingham adds, noting that Solana MedSpas will the first medspa network to offer an adult stem cell collection service. "As Solana MedSpas continue to orchestrate the marriage of healthcare product innovation with our ever expanding medspa distribution channel, the addition of LifeStem's Stem Cell MicroBank(TM) Service to our locations, not only positions Solana MedSpas as unique vis-a-vis the competition, but it represents the next logical step in the realization of our vision and mission as a syndicator of medical spas."
About CalbaTech
CalbaTech, Inc. (OTC Bulletin Board: CLBE - News) is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions.
About LifeStem
LifeStem, a wholly owned subsidiary of CalbaTech, is positioning itself to become a leading supplier of "Cellular Logistics." The Company's focus is to provide services and technologies to facilitate the efficient acquisition and delivery of adult stem cells, development of stem cell delivery devices for clinical applications and clinical applications of specific stem cell based therapies. LifeStem, in addition to being the first company to offer micro collection of stem cells, is also the first company to offer a collection service that collects and stores two different types of stem cells. The Company has filed patent applications for an endoscopic stem cell delivery device and its novel Stem Cell MicroBank(TM) service.
About Solana MedSpas
Founded in July 2003, Solana MedSpas is the nation's innovative leader in the development and syndication of medical spas. Solana MedSpas has created a new market segment by combining aesthetic healthcare with the spa movement, coming from the medical and educational side rather than the spa side. Solana MedSpas makes its proprietary content simultaneously available to its growing distribution network of uniquely branded medical spa facilities all over North America. Solana MedSpas provides the industry's only model for legally compliant, competitive, and forward-thinking business in all 50 states.
Contact:
Paul Knopick E&E Communications
(949) 707-5365
pknopick@eandecommunications.com
Note: Certain statements in this news release may contain "forward looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, may include forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements.
XKEM is still play of the week IMO.
CLBE chart
Ready to launch anyday now. Just needs volume.
CLBE chart
Ready to launch anyday now.
XKEM my pick of the week.
XKEM indicators show increasing momentum/accumulation. Looks to me like a possible 5 day run.
XKEM has a lot of room to run. It was pushed down hard and fast when it should have maintained an uptrend.
My take is that is was pushed down so the company could repurchase the outstanding convertible debt, per January PR. "Xechem Completes Repurchase of $3 Million Convertible Loan From Alembic - Thursday January 12, 6:30 am ET"
Add this to collecting the settlement money ("Xechem Closes On $4.2 Million Lawsuit Settlement With Bristol-Meyers Squibb - Wednesday January 25, 6:30 am ET") and you have a company in a MUCH better position than when it was trading @ .03 with a LOT more interest.
Now its returning to its fair value with massive momentum behind it. It should push through critical resistance pivots without a problem. XKEM is easy money from these levels IMO.
CLBE chart
Sky is clear once volume kicks in. The first spike a month ago happened with no news. IMO smart money was front loading. Now they're basing it for news. Huge revenue growth potential, many patents and educated BOD
bb, been loading the truck on XKEM since the low .007's. It's got strong legs. Monday it should rally again, pushing it through the 200MA hard.
I'm looking for a 5 day run before a retrace. To many indicators going off in tight succession.
Pacific Sands Sets Launch Date For EcoOne Earth, Health and Kid Friendly Household Cleaning Product Line - Company to Partner With 5 Million-Member Environment / Health Information Website in Initial Marketing Push
Friday February 24, 8:39 am ET
RACINE, Wis.--(BUSINESS WIRE)--Feb. 24, 2006--Pacific Sands, Inc. (OTCBB:PFSD - News) is pleased to announce that the company has set May 1, 2006 as the launch date for its' EcoOne line of nontoxic, earth, health, child and pet-friendly cleaning products.
Management opted to accelerate the launch of these products following a highly successful market test where 100% of those surveyed responded favorably to their efficacy, comparison to currently available products and other determining factors.
Pacific Sands will support the launch of the products through a high-impact, brand awareness and direct sales campaign in partnership with the Internet's most popular environmental website, marketing directly to their more than 5 million registered user database. The site draws in excess of 60 million page views per month and demographics consist of approximately 85% professional women with annual incomes in excess of $75,000. The company has begun establishing retail and distribution outlets and is currently taking pre-orders.
The majority of the products offered are based on Pacific Sands' core, award winning cleaning and water treatment technology which, in a preliminary marketability study conducted by the Wal-Mart Innovation Network, received the highest "Success Likelihood Score" ever granted in that program's 22 year history. The founder of the program, Dr. Gerald Udel had this to say in his summary of the evaluation: "(Pacific Sands) has a classic hinge pin technology (and) such technologies are quite rare. Few technological innovations have so many potential applications and therefore, so many opportunities for success"
The products will be offered in whole-house kit solutions, each designed for specific user groups, particularly people with pets, children and environment / health concerns. The multi-product kits will contain a selection of products including EcoOne All-Purpose Household Cleaner, Lemongrass Window and Glass Cleaner, Kitchen and Bath Cleaners, Spot and Stain Removers, Carpet Shampoo, Baby's Nursery Spray and other special application products. The kits will range in price between $25 and $49 per unit and individual products will retail between $3.95 and $7.95.
With a particular emphasis on child safety and indoor air quality, all of the Eco One products contain no VOC's, are chlorine and ammonia free and rival the performance, cost and quality of conventional products available on store shelves today.
Pacific Sands, Inc. is a fully reporting NASDAQ OTCBB company that develops, manufactures and markets environmentally safe, nontoxic cleaning and water treatment solutions. For product inquiry, please contact Michael.Michie@pacificsandsinc.com or call 877-492-8123. Website: www.pacificsandsinc.com
Safe Harbor Act Disclaimer
The statements contained in this release and statements that the company may make orally in connection with this release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected in the forward-looking statements, since these forward-looking statements involve risks and uncertainties that could significantly and adversely impact the company's business. Therefore, actual outcomes and results may differ materially from those made in forward-looking statements.
Contact:
Pacific Sands, Inc.
JT Ploch, 608-577-6482
XKEM intraday 5 minute chart looks awesome. Massive buy pressure
XKEM intraday 5 minute chart looks awesome. Massive buy pressure
XKEM RSI hasn't even peaked out yet. 200 DMA breakout coming.